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CASE REPORT
Behcet’s disease is a chronic, recurrent, multisys-
temic inflammatory disorder without definite eti-
ology. It occurs worldwide, but has the highest
incidence in Japan and Eastern Mediterranean
countries.1 Currently, the most commonly used
diagnostic criteria are those of the International
Study Group for Behcet’s disease or the revised
diagnostic criteria of the Behcet’s Disease Research
Committee of Japan.1 Behcet’s disease can be di-
vided into three subtypes: neuro-, entero-, and
vasculo-Behcet’s disease.2 Cardiovascular compli-
cations are uncommon (7–29%), especially those
that involve the heart or aorta, but frequently they
are associated with mortality and morbidity.3
Here, we report a patient without a diagnosis
of Behcet’s disease, until aortitis with severe aortic
regurgitation was demonstrated.
Case Report
A 24-year-old woman who denied any systemic
disease was admitted because of intermittent chest
tightness and progressive exertional dyspnea for
6 months. Auscultation revealed a grade 2/6 sys-
tolic sea-gull murmur and a grade 3/6 diastolic
murmur at the left middle sternal border. Her
blood pressure was 96/40 mmHg and her heart
rate was 80 beats/min. Upon detailed review, she
had no significant known medical history, but
had recurrent aphthous and genital ulcers, 
and skin lesions for 2 years. Hence, Behcet’s dis-
ease, incomplete form, was suspected and a
work-up was performed. C-reactive protein was
2.06 mg/dL (normal range,<0.6 mg/dL). The ery-
throcyte sedimentation rate was 66 mm/hour
and > 120 mm/2 hours. The complement C3 and
C4 levels were within normal limits and the 
autoantibodies (including antinuclear antibody,
anti-extractable nuclear antigen, and rheumatoid
factor) were negative. The Venereal Disease
Research Laboratory test was non-reactive.
Electrocardiography showed left ventricular
(LV) hypertrophy. Echocardiography revealed
moderate-to-severe eccentric aortic regurgitation
and marked LV enlargement with suboptimal
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contractility (LV end-diastolic dimension, 6.4 cm;
ejection fraction, 58%). Cardiac catheterization
showed that the LV end-diastolic pressure was
8 mmHg, the systemic blood pressure was 90/
36 mmHg, and the pulmonary artery pressure
was 22/8 mmHg. Aortography at the aortic root
revealed severe aortic regurgitation without aor-
tic valve prolapse (Figure 1). There were irregu-
larities in the ascending aortic wall, without
dilatation. Hence, Behcet’s disease with aortitis
was confirmed.
The patient underwent aortic valve replace-
ment with a 19-mm St. Jude RegentTM mechani-
cal valve (St. Jude Medical, Inc., St. Paul, MN,
USA) and aortoplasty. Thickened aortic valve
with impaired coaptation, irregular and thick-
ened aortic wall with supravalvular aortic ste-
nosis, dilated LV chamber, and a small amount
of pericardial effusion were found during surgery
(Figure 2). The histological examination revealed
myxomatous degeneration with mild lympho-
cytic infiltration. The postoperative course was
uneventful. Immunosuppressant, anticoagulant,
and anti-failure treatment was given. Follow-
up echocardiography showed normalized LV 
dimensions with improved contractility, and C
reactive protein level returned to normal. After
2.7 years follow-up her current condition is sta-
tionary in New York Heart Association func-
tional class I.
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Figure 1. Ascending aortogram with (A) right anterior oblique view and (B) lateral view showing irregular ascending 
aortic wall with severe aortic regurgitation.
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Figure 2. (A) Irregular and thickened aortic wall (arrow) with supravalvular aortic stenosis, (B) thickened aortic valve with
impaired coaptation (arrow), dilated left ventricular chamber, and a small amount of pericardial effusion, were found
during surgery.
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Discussion
Vasculo-Behcet’s disease is a rare systemic vasculi-
tis that involves large vascular lesions. Three major
manifestations in order of frequency are: venous
occlusion, arterial occlusion, and arterial aneu-
rysm formation.2 Treatment of Behcet’s disease 
is symptomatic and empirical but remains unsat-
isfactory because of variable manifestations with
uncertain etiology and pathogenesis. However,
most presentations are responsive to corticoste-
roids and possibly additional immunosuppres-
sant therapy.2,3 In our patient, the diagnosis of
Behcet’s disease was delayed until aortitis with
severe aortic regurgitation was noted. No steroid
or immunosuppressant therapy was administered
preoperatively. This might be the reason that, to
the best of our knowledge, our patient is the
youngest case of Behcet’s aortitis to undergo sur-
gical management. This emphasizes the impor-
tance of steroid treatment to delay the onset of
aortitis symptoms.
Aortitis with or without valvulitis complicating
Behcet’s disease is extremely rare and frequently
results in significant aortic regurgitation with he-
modynamic decompensation,4,5 for which surgi-
cal management is usually required, but difficult
because of the inflammatory and fragile tissue.2,5
The most serious complications after surgical
treatment are prosthetic valve detachment, bypass
graft occlusion, and pseudoaneurysm formation.4
Ando et al reported a high prosthetic valve detach-
ment rate of 40% and a low 5-year freedom from
reoperation (64%) in patients with Behcet’s dis-
ease, in contrast to 4.6% and 96%, respectively, of
those with Takayasu’s arteritis.5 The cause of the
differences between the two diseases is still un-
known. In a study by Okada et al, the reoperation
rate was 7.4% per patient-year and the mortality
rate was 3.7% per patient-year.6
Several surgical techniques have been devel-
oped to lower the complication rate, including the
translocated Bentall procedure, Cabrol’s method,
and valved conduit reconstruction.3,5,6 Preopera-
tive steroid administration is recommended to
reduce inflammation. However, postoperative
steroid therapy is controversial. In a study by
Isomura et al, early postoperative steroid therapy
increased the susceptibility to infection, distur-
bance of wound healing, and valvular detach-
ment.7 However, Ando et al and Suzuki et al
suggested that continuous postoperative steroid
administration has the benefit of inflammation
control, and reduces the incidence of complica-
tions, especially those in the active inflammatory
stage.5,8
In patients with Behcet’s disease or other au-
toimmune diseases, aortitis or other cardiovascu-
lar complications should be evaluated carefully
in those with chest discomfort. Steroid admin-
istration is important, especially preoperatively,
which not only decreases inflammatory reactions,
but also reduces the postoperative steroid dosage
and diminishes the associated side effects.4–6
Moreover, because of high reoperation and mor-
tality rates, long-term follow-up is mandatory
after surgery.
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